Impact of Prostatic Urethral Lift and Water Vapor Energy Therapy on Bladder Outlet Obstruction in Elderly or Comorbid Patients With Benign Prostatic Hyperplasia in Real‐World Clinical Practice
Neurourology and Urodynamics · 2026-01 · 45 (1) · 105-114
DOI: 10.1002/nau.70149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, online erschienen am 24.09.2025. Verfasst von Yuki Kyoda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Urinary Bladder Neck Obstruction, Urethra, Laser Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objective
To evaluate the effects of prostatic urethral lift (PUL) and water vapor energy therapy (WAVE) on bladder outlet obstruction (BOO) using pressure flow studies (PFS) in real‐world clinical practice among patients with benign prostatic hyperplasia (BPH), particularly those who are elderly or in poor general health.
Methods
This retrospective study included 128 men who underwent PUL ( n = 43), WAVE ( n = 38), or photoselective vaporization (PVP, n = 47) for BPH. Surgical procedure selection was based on a department‐specific proprietary algorithm. In elderly patients or those with systemic comorbidities, either PUL or WAVE was selected, and the choice between the two procedures was made based on prostate morphology. The primary endpoint was the change in bladder outlet obstruction index (BOOI) from baseline to 6 months after each surgical procedure.
Results
The BOOI (mean ± SD) significantly decreased from 59.5 ± 26.2 to 14.8 ± 16.7 after PVP, 39.7 ± 21.8 to 25.8 ± 17.7 after PUL, and 52.5 ± 23.9 to 21.9 ± 19.2 after WAVE (all p < 0.01). The International Prostate Symptom Score (IPSS) improved from 17.0 ± 8.8 to 7.0 ± 6.2 (PVP), 16.7 ± 9.0 to 11.5 ± 7.9 (PUL), and 14.7 ± 8.0 to 8.2 ± 6.3 (WAVE) (all p < 0.01). Maximum flow rate (Qmax) increased from 8.6 ± 5.0 to 17.3 ± 7.5 mL/s (PVP), 9.3 ± 5.9 to 12.5 ± 5.8 mL/s (PUL), and 9.2 ± 3.7 to 12.4 ± 6.0 mL/s (WAVE) (all p < 0.01). Despite improvements, residual BOO (Schafer grade ≥ III) remained in 6.4% of PVP, 16.3% of PUL, and 15.8% of WAVE patients.
Conclusion
In elderly patients or those with poor general health, both PUL and WAVE significantly improved the BOOI at 6 months postoperatively. However, in PUL and WAVE, persistent BOO exceeded 15%, suggesting that more appropriate patient selection will be necessary in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sapporo Medical University School of Medicine, Sapporo, Japan.
ORCID-Profile: Yuki Kyoda, Tetsuya Shindo, Naoya Masumori
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Kyoda, Y., Saito, Y., Kozen, N., Shindo, T., Hashimoto, K., Kobayashi, K., Tanaka, T., & Masumori, N. (2026). Impact of Prostatic Urethral Lift and Water Vapor Energy Therapy on Bladder Outlet Obstruction in Elderly or Comorbid Patients With Benign Prostatic Hyperplasia in Real‐World Clinical Practice. Neurourology and Urodynamics, 45(1), 105-114. https://doi.org/10.1002/nau.70149
Vancouver
Kyoda Y, Saito Y, Kozen N, Shindo T, Hashimoto K, Kobayashi K, et al. Impact of Prostatic Urethral Lift and Water Vapor Energy Therapy on Bladder Outlet Obstruction in Elderly or Comorbid Patients With Benign Prostatic Hyperplasia in Real‐World Clinical Practice. Neurourology and Urodynamics. 2026;45(1):105-114. doi:10.1002/nau.70149
BibTeX
@article{Kyoda2026,
author = {Kyoda, Yuki and Saito, Yoko and Kozen, Nodoka and Shindo, Tetsuya and Hashimoto, Kohei and Kobayashi, Ko and Tanaka, Toshiaki and Masumori, Naoya},
title = {Impact of Prostatic Urethral Lift and Water Vapor Energy Therapy on Bladder Outlet Obstruction in Elderly or Comorbid Patients With Benign Prostatic Hyperplasia in Real‐World Clinical Practice},
journal = {Neurourology and Urodynamics},
year = {2026},
volume = {45},
number = {1},
pages = {105--114},
doi = {10.1002/nau.70149}
}
EUVIMED